These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15157034

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring.
    Maida V, Ennis M, Irani S, Corbo M, Dolzhykov M.
    J Support Oncol; 2008 Mar; 6(3):119-24. PubMed ID: 18402303
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Symptom priority and course of symptomatology in specialized palliative care.
    Strömgren AS, Sjogren P, Goldschmidt D, Petersen MA, Pedersen L, Groenvold M.
    J Pain Symptom Manage; 2006 Mar; 31(3):199-206. PubMed ID: 16563314
    [Abstract] [Full Text] [Related]

  • 29. A survey of the adequacy of pain management in end-stage cancer patients.
    Cork RC, Saleemi S, Ibrahim I, Mansour R, Alexander L.
    J La State Med Soc; 2003 Mar; 155(3):150-3. PubMed ID: 12873101
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Mar; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer.
    Goodchild CS, Nelson J, Cooke I, Ashby M, Jackson K.
    Pain Med; 2008 Oct; 9(7):939-49. PubMed ID: 18950447
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Critical issues on opioids in chronic non-cancer pain: an epidemiological study.
    Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK.
    Pain; 2006 Nov; 125(1-2):172-9. PubMed ID: 16842922
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S.
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [Abstract] [Full Text] [Related]

  • 39. The relationship between hope and pain in a sample of hospitalized oncology patients.
    Utne I, Miaskowski C, Bjordal K, Paul SM, Jakobsen G, Rustøen T.
    Palliat Support Care; 2008 Dec; 6(4):327-34. PubMed ID: 19006586
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG, Orońska A, Kaczmarek Z, Kaasa S, Colberg T, Nolte T.
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.